Malaquin, N.; Vancayseele, A.; Gilbert, S.; Antenor-Habazac, L.; Olivier, M.-A.; Ait Ali Brahem, Z.; Saad, F.; Delouya, G.; Rodier, F.
DNA Damage- But Not Enzalutamide-Induced Senescence in Prostate Cancer Promotes Senolytic Bcl-xL Inhibitor Sensitivity. Cells 2020, 9, 1593.
https://doi.org/10.3390/cells9071593
AMA Style
Malaquin N, Vancayseele A, Gilbert S, Antenor-Habazac L, Olivier M-A, Ait Ali Brahem Z, Saad F, Delouya G, Rodier F.
DNA Damage- But Not Enzalutamide-Induced Senescence in Prostate Cancer Promotes Senolytic Bcl-xL Inhibitor Sensitivity. Cells. 2020; 9(7):1593.
https://doi.org/10.3390/cells9071593
Chicago/Turabian Style
Malaquin, Nicolas, Arthur Vancayseele, Sophie Gilbert, Laureen Antenor-Habazac, Marc-Alexandre Olivier, Zakia Ait Ali Brahem, Fred Saad, Guila Delouya, and Francis Rodier.
2020. "DNA Damage- But Not Enzalutamide-Induced Senescence in Prostate Cancer Promotes Senolytic Bcl-xL Inhibitor Sensitivity" Cells 9, no. 7: 1593.
https://doi.org/10.3390/cells9071593
APA Style
Malaquin, N., Vancayseele, A., Gilbert, S., Antenor-Habazac, L., Olivier, M. -A., Ait Ali Brahem, Z., Saad, F., Delouya, G., & Rodier, F.
(2020). DNA Damage- But Not Enzalutamide-Induced Senescence in Prostate Cancer Promotes Senolytic Bcl-xL Inhibitor Sensitivity. Cells, 9(7), 1593.
https://doi.org/10.3390/cells9071593